Gilman Hill Asset Management, LLC Laboratory Corp Of America Holdings Transaction History

Gilman Hill Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 19, 2023	BUY	$203.72 - $248.97 $11,408 - $13,942	56 Added 3.16%	1,828 $0
Q3 2021 Oct 13, 2021	SELL	$274.82 - $308.34 $27,482 - $30,833	-100 Reduced 5.34%	1,772 $499,000
Q1 2021 Apr 19, 2021	BUY	$204.88 - $255.03 $55,727 - $69,368	272 Added 17.0%	1,872 $477,000
Q4 2020 Jan 19, 2021	BUY	$186.91 - $214.42 $18,691 - $21,442	100 Added 6.67%	1,600 $326,000
Q2 2020 Jul 20, 2020	BUY	$113.31 - $182.44 $169,965 - $273,660	1,500 New	1,500 $249,000
Q1 2020 Apr 22, 2020	SELL	$104.32 - $195.28 $156,480 - $292,920	-1,500 Closed	0 $0
Q1 2019 Apr 24, 2019	BUY	$123.7 - $156.3 $185,550 - $234,450	1,500 New	1,500 $229,000
Q4 2018 Jan 29, 2019	SELL	$120.82 - $174.09 $181,230 - $261,135	-1,500 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$149.47 - $160.56 $224,205 - $240,840	1,500	1,500 $226,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Gilman Hill Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gilman Hill Asset Management, LLC with notifications on news.